When is the next full moon? June's Strawberry Moon rises Tuesday night
Ready to see a cosmic phenomenon in the night sky?
There's a full moon rising tonight, and it won't be regular. June's Strawberry Moon will be different celestial event that won't be seen again until 2043.
According to skyatnightmagazine.com, it will be the lowest laying full moon seen north of the equator, as well as one of the farthest from the sun. Because the moon is near its farthest point from Earth, it'll appear slightly smaller and dimmer.
The Strawberry Moon is the final full moon of the spring in the Northern Hemisphere that signals the coming of the summer solstice.
Each full moon name derives from natural event occuring such as seasonal changes used by Native American, Colonial American and European sources.
According to the Old Farmer's Almanac, The Strawberry Moon name comes not from its color, but from the Algonquin tribes in North America, who saw this full Moon as the signal that wild strawberries were ready for harvest.
The moon will reach its peak and become full visible at 3:45 a.m. EDT on Wednesday, June 11, but the best time so see it will be as it rises on June 10, according to LiveScience.com.
The moon rising occurs at different times depending on locations. Moonset in Monmouth and Ocean counties for June 10, 2025, is at 8:25 pm. All times are Eastern Daylight Time.
This article originally appeared on Asbury Park Press: June 2025 full moon: How to see Strawberry Moon in New Jersey
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Photos: Strawberry Moon wows across the world
June's Strawberry Moon put on a show around the world with a slight berry hue and a view low on the horizon for the first time since last summer. The Strawberry Moon reached peak illumination around 3 a.m. on Wednesday and appeared full and bright on Tuesday evening. The video at the top of this story was taken on Tuesday from Chicago, where the lucky photographer captured a helicopter and plane passing in front of the glowing Moon. The final full Moon of spring is named the Strawberry Moon for the time when the berries are ripe for picking and also the slight reddish hue because it is lower in the sky. "When it spends more of that time in that lower portion of the sky, you're looking through more of Earth's atmosphere, which makes these moons generally look redder and more golden," said Dr. Tyler Richey-Yowell, a postdoctoral fellow at Lowell Observatory in Arizona. This golden glow was on display Tuesdsay night in New York City, where the Empire State Building and the Moon made a beautiful pair. How To Photograph The Moon With Your Phone In Florida, SpaceX's Falcon 9 rocket and Dragon spacecraft presented a trifecta of space with the Moon looming large in the night sky. Saharan dust moving up the Southeast coast could have contributed to the yellow and orange tint of the Moon on Tuesday. Wildfire smoke provided an added boost to the red coloring of the Moon in Columbus, Ohio, as the image below shows. In the United Kingdom, the Moon appeared berry red near the northeast coast of England along Whitley Bay. A golden Moon appeared peaking out from behind the mausoleum of Mustafa in Turkey on Tuesday in the creatively set image article source: Photos: Strawberry Moon wows across the world
Yahoo
2 hours ago
- Yahoo
Ancient Romans snacked on deep-fried songbirds
Fast food didn't start with McDonald's—quick, convenient meals have been a dietary staple of busy societies for millennia. Across the Roman empire, roadside shops known as popinae and tabernae often served up inexpensive, affordable dishes to hungry locals and travelers alike. But after scouring ancient garbage piles near one such popina in Mallorca, Spain, archeologists are better understanding how certain entrées transcended class divisions more often than previously thought. According to findings recently published in the International Journal of Osteoarchaeology, Roman commoners frequently enjoyed dining on thrushes—small songbirds once thought to be a luxury dish. Birds were prominent figures in ancient Rome. Certain owls and eagles were considered powerful divinatory omens, while smaller avian species like thrushes were popular as both pets and meals. In the latter case, however, ancient texts suggest thrushes were primarily eaten by wealthier Romans. 'Classical sources frequently describe these small birds as a delicacy served in elite banquets, often prepared with elaborate culinary techniques,' the study's authors write. They also cite recipes documented by Pliny the Elder and Apicius that described fattening songbirds with figs before roasting and serving them with complex sauces. These assumptions were recently challenged by finds at an excavation in Mallorca, Spain. There, archeologists from the Mediterranean Institute for Advanced Studies (IMEDEA) uncovered a large cesspit beside a roadside popina snack bar. The building also featured six amphorae (large vats) embedded in its countertop in a configuration like the one seen in Pompeii's famous street food court, or thermopolia. Amid the refuse were 165 thrush bones alongside other common food remains like sea shells as well as fish and pig bones. The condition of the songbirds' broken bones suggest that they were flattened and cooked whole with oil in the amphorae. In addition to the thrushes, archeologists also documented remains from domesticated chickens and European rabbits. These point to a wider menu tailored to everyday customers. Taken altogether, it appears that thrushes were served up similar to today's sports bar chicken wings. The food shop in Mallorca isn't the only example of deep-fried songbirds across Rome. As Arkeonews notes, additional finds in Pompeii and Britain indicates a widespread culture of ancient Roman fast food. 'Thrushes, though a minor component of the Roman diet compared to livestock, represent an important facet of urban food consumption,' the study's authors conclude. 'Ultimately, this research highlights the need to move beyond elite-centric narratives and consider the diverse ways in which food practices shaped the lived experiences of ancient urban communities.'
Yahoo
3 hours ago
- Yahoo
SpliceBio lands $135M for a new kind of eye gene therapy
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. SpliceBio, a Spanish biotechnology company working on next-generation gene therapies, said Wednesday it raised $135 million in a Series B round to advance its lead program in Stargardt disease into further clinical testing. The startup is built around a technology that's meant to overcome a key limitation of current gene therapies. Scores of gene therapy developers use adeno-associated viruses, or AAVs, to deliver genetic cargo into the body. But because of their small size, AAVs can't carry larger corrective genes, leaving many diseases out of reach or forcing companies to come up with creative solutions. One example is in Duchenne muscular dystrophy. Because of the large size of the gene coding for the muscle-protecting protein dystrophin Duchenne patients lack, several companies, like Sarepta Therapeutics, have developed gene therapies that make a shortened form. The approach comes with drawbacks, however, as a truncated version of the protein might not work as well as the original. SpliceBio has a different workaround. The company is using two separate AAVs to send pieces of a large gene into cells. Once inside, specially engineered splicing molecules help reassemble their cargo into full-length proteins. Stargardt disease, for example, is caused by mutations to the ABCA4 gene, which is too large to stuff into an AAV. SpliceBio says its method can help the body produce a functional version of the protein that gene produces. Its lead program, SB-007, is in a Phase 1/2 trial. SpliceBio isn't the only biotech pursuing this type of approach to treat Stargardt, an inherited eye condition that causes progressive vision loss. Another European company, AAVantgarde, has a similar type of program in early-stage testing. SpliceBio's technology is based on research conducted at Princeton University, where co-founder and CEO Miquel Vila-Perelló was studying protein design and engineering. Launched in 2014 under the name ProteoDesign, the biotech is also working on additional programs in ophthalmology, neurology and other undisclosed therapeutic areas. Its Series B round was co-led by EQT Life Sciences and Sanofi Ventures, and involved seven other backers including Roche Venture Fund, New Enterprise Associates and Novartis Venture Fund. "The support from such high-quality investors underscores the strength of our programs and our unique protein splicing platform and its potential to unlock gene therapies for diseases that remain untreatable today,' Vila-Perelló said in a statement. The company raised €50 million in a Series A round in 2022. Gene and cell therapy startups backed by the roughly two dozen investment firms BioPharma Dive tracks have secured a little over $1.1 billion in venture dollars so far in 2025. Half of those fundings have come in the form of 'megarounds' exceeding $100 million apiece, continuing an ongoing trend. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
